GlobeNewswire: Eve & Co Incorporated Contains the last 10 of 95 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:55:16ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/02/18/2387889/0/en/Eve-Co-Announces-Closing-of-Shares-for-Debt-Transaction.html?f=22&fvtc=4&fvtv=44826Eve & Co Announces Closing of Shares for Debt Transaction2022-02-18T12:30:00Z<![CDATA[STRATHROY, Ontario, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has closed its previously announced shares for debt transaction (the “Transaction”) whereby it settled $657,000 in payables (the “Payables”) owed to certain directors, officers, employees, and debentureholders related to expenses, loans, and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,607 common shares in the capital of the Company (the “Settlement Shares”). The Company issued the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes.]]>https://www.globenewswire.com/news-release/2022/01/31/2375801/0/en/Eve-Co-Announces-Shares-for-Debt-Transaction.html?f=22&fvtc=4&fvtv=44826Eve & Co Announces Shares for Debt Transaction2022-01-31T13:30:15Z<![CDATA[STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has entered into debt settlement agreements (the “Debt Settlement Agreements”) with certain directors, officers, employees, and debentureholders (the “Parties”) whereby it has agreed to settle an aggregate of $657,000 in payables (the “Payables”) owed to the Parties related to expenses, loans and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,606 common shares in the capital of the Company (the “Settlement Shares”). The Company is proposing to issue the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes.]]>https://www.globenewswire.com/news-release/2021/11/25/2341280/0/en/Eve-Co-Incorporated-Financial-Results-for-the-Nine-Months-Ended-September-30-2021.html?f=22&fvtc=4&fvtv=44826Eve & Co Incorporated Financial Results for the Nine Months Ended September 30, 20212021-11-25T22:10:10Z<![CDATA[Revenues up 222% to $2.5m and 154% to $6.5m for the three and nine month periods over last year Revenues up 222% to $2.5m and 154% to $6.5m for the three and nine month periods over last year]]>https://www.globenewswire.com/news-release/2021/09/30/2306087/0/en/Eve-Co-Incorporated-Announces-Director-and-Management-Changes.html?f=22&fvtc=4&fvtv=44826Eve & Co Incorporated Announces Director and Management Changes2021-09-30T11:30:00Z<![CDATA[STRATHROY, Ontario, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) today announces that Jeannette VanderMarel has joined the Board of Directors of Eve & Co.]]>https://www.globenewswire.com/news-release/2021/09/29/2305263/0/en/Eve-Co-Announces-Closing-of-Private-Placement.html?f=22&fvtc=4&fvtv=44826Eve & Co Announces Closing of Private Placement2021-09-29T11:30:00Z<![CDATA[NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES]]>https://www.globenewswire.com/news-release/2021/08/19/2283186/0/en/Eve-Co-Announces-Revenues-of-4-0M-in-the-First-Half-of-2021-and-Financial-Results-for-the-Six-Months-Ended-June-30-2021.html?f=22&fvtc=4&fvtv=44826Eve & Co. Announces Revenues of $4.0M in the First Half of 2021 and Financial Results for the Six Months Ended June 30, 20212021-08-19T00:15:57Z<![CDATA[STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), through its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) is pleased to announce that it has made gross revenues of $4.0 million in the first six months of 2021, successfully surpassing its gross revenues of $3.8 million for the entire 2020 financial year.]]>https://www.globenewswire.com/news-release/2021/08/18/2282611/0/en/Eve-Co-Announces-Medical-Cannabis-Supply-Purchase-Agreement-with-Australian-Distributor-TCann-Pty-Ltd.html?f=22&fvtc=4&fvtv=44826Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement with Australian Distributor TCann Pty Ltd.2021-08-18T11:30:00Z<![CDATA[STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Medical Cannabis Supply and Purchase Agreement (the “Agreement”) with TCann Pty Ltd., Australia (“TCann”), an import/export and distribution company of para-pharmaceutical, medicinal and narcotic products located in Thornleigh, New South Wales.]]>https://www.globenewswire.com/news-release/2021/08/11/2278636/0/en/Eve-Co-Completes-its-Largest-to-Date-Shipment-of-Cannabis-to-Germany.html?f=22&fvtc=4&fvtv=44826Eve & Co Completes its Largest to Date Shipment of Cannabis to Germany2021-08-11T11:00:00Z<![CDATA[STRATHROY, Ontario, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce that it has, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), successfully completed its largest shipment of cannabis to a customer in German with a retail value of $1.8M CAD. Eve & Co received its European Union certificate of Good Manufacturing Practice (“EU-GMP certification”) in March of 2020, undertook the required shipments for scientific purposes in the summer of 2020 and has continued to complete regular commercial shipments to its customers in Germany since the fourth quarter of 2020.]]>https://www.globenewswire.com/news-release/2021/07/19/2264684/0/en/Eve-Co-Announces-Medical-Cannabis-Supply-Purchase-Agreement-With-Cannamedical-Pharma-GmbH.html?f=22&fvtc=4&fvtv=44826Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement With Cannamedical Pharma GmbH2021-07-19T11:00:00Z<![CDATA[STRATHROY, Ontario, July 19, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Medical Cannabis Supply and Purchase Agreement (the “Agreement”) with Cannamedical Pharma® GmbH (“CM”), an import / export and distribution company of para-pharmaceutical, medicinal and narcotic products headquartered in Cologne, Germany.]]>https://www.globenewswire.com/news-release/2021/07/13/2261761/0/en/Eve-Co-Announces-Cannabis-Supply-Agreement-With-Adjupharm-GmbH-and-Provides-a-Corporate-Update.html?f=22&fvtc=4&fvtv=44826Eve & Co. Announces Cannabis Supply Agreement With Adjupharm GmbH and Provides a Corporate Update2021-07-13T11:00:00Z<![CDATA[STRATHROY, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Cannabis Supply Agreement (the “Agreement”) with Adjupharm GmbH (“AP”), an importer, exporter and distributor of para-pharmaceutical, medicinal and narcotics, headquartered in Bad Oldesloe, Germany.]]>